Skip to main content
. 2022 Jul-Aug;67(4):381–386. doi: 10.4103/ijd.ijd_571_22

Table 4.

Treatment options in PsA

Type of Treatment Name Comments
Non-pharmacologic therapies[36] Physical exercise
Diet adjustment
Occupational therapy
Cessation of smoking
Help improvement treatment outcome; not enough on their own.
NSAIDs[37] Naproxen
Ibuprofen
First line in mild-to-moderate disease. Relieves symptoms but does not stop progression of disease.
DMARDs[37] Methotrexate
Leflunomide
Sulfasalazine
Older drugs, no longer preferred as first-line. Can decrease or reverse disease progression.
Biologicals[35] (preferred over DMARDs now):
TNF-alpha inhibitors Infliximab
Adalimumab
Etanercept
First-line, more effective.
IL-17 inhibitors Seckinumab
Ixekizumab
Choice after TNF alpha inhibitors
IL 12/23 inhibitor Ustekinumab
IL 23 inhibitor Guselkumab
T-cell co stimulator Abatacept
JAK inhibitor Tofacitinib Newly introduced
PDE4 inhibitor Apremilast Newly introduced, may be used first-line.

PsA=psoriatic arthritis, NSAIDs=non-steroidal anti-inflammatory drugs, DMARDs=conventional Disease modifying anti-rheumatic drugs, TNF= Tumour necrosis factor, JAK= Janus kinase, PDE4= Phosphodiesterase 4, IL= Interleukin